Raina Biosciences has introduced GEMORNA, a deep generative AI platform designed to engineer mRNA sequences with enhanced translational efficiency and stability for therapeutic applications. Published in Science, GEMORNA delivers up to 41-fold higher expression in vitro and enhances in vivo efficacy, including vaccine and CAR-T cell applications. The platform also extends capabilities to circular RNA therapeutics, potentially accelerating mRNA drug discovery and expanding the scope of mRNA-based treatments beyond infectious diseases to oncology and gene therapy.